Informatics Strategies for Life Science R&D
How to Evaluate and Implement New Technologies
Featuring Research from Gartner
The drive to constrain costs and maximize resources leads life science companies to continually evaluate which emerging technologies will help drive innovation and bring new efficiencies to their operations. This technology landscape is constantly changing, both in terms of a technology's particular maturity and capabilities, and in how each technology aligns with the current marketplace.

I invite you to explore Gartner's recent research into the current priority matrix for emerging life science R&D technologies, and how to best approach new implementation strategies. 
Plus, learn how BIOVIA can become a trusted partner in the digital transformation of your organization.
Evaluating emerging and advanced technologies in the Life Science R&D space 
CIOs are moving from strategy into the execution phase for digital R&D and are implementing a range of technologies to develop new drugs, devices and therapies. Success requires leaders to choreograph a diverse set of scientific, laboratory and clinical technologies in a fluid business environment.

Gartner's recent research evaluates the current stage of their priority matrix for emerging technologies in the life science R&D landscape and provides guidance for implementing these technologies in a pragmatic manner. 
Jason Benedict
VP Software Development
Dassault Systèmes BIOVIA
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.